Strong Performance in EMEA, LatAm, and APAC
EMEA, LatAm, and APAC regions were well within the company's medium-term 4% to 6% organic sales growth guidance. Volume growth accelerated in these regions, with EMEA and LatAm seeing improvements from Q1 to Q2, and Asia Pacific achieving 3.9% growth in Q2.
Gross Margin and Cash Flow Improvements
The company experienced a 160 basis point improvement in gross margin and strong cash flow, attributed to supply chain productivity and a reduction of SKUs.
Positive Developments in Oral Health
Haleon gained 0.5 share points in Oral Health in the U.S. during the first half, and there was strong growth and market share gains in brands like Tums and Benefiber.